Verma, S., & McMurray, J. J. V. (2018). SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review. Diabetologia, 61(10), 2108-2117. https://doi.org/10.1007/s00125-018-4670-7
Citácia podle Chicago (17th ed.)Verma, Subodh, a John J. V. McMurray. "SGLT2 Inhibitors and Mechanisms of Cardiovascular Benefit: A State-of-the-art Review." Diabetologia 61, no. 10 (2018): 2108-2117. https://doi.org/10.1007/s00125-018-4670-7.
Citácia podľa MLA (8th ed.)Verma, Subodh, a John J. V. McMurray. "SGLT2 Inhibitors and Mechanisms of Cardiovascular Benefit: A State-of-the-art Review." Diabetologia, vol. 61, no. 10, 2018, pp. 2108-2117, https://doi.org/10.1007/s00125-018-4670-7.
Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..